This editorial refers to 'Novel role of Egr-1 in nicotine related neointimal formation' by R.I. Vazquez-Padron et al., pp. 296 -303, this issue.
Vascular proliferative diseases such as atherosclerosis, restenosis after arterial injury, and hypertensive vascular diseases are commonly associated with the proliferation of vascular smooth muscle cells (VSMCs). Multiple stimuli such as shear stress, 1 3 bFGF, 7 and tissue factor 8 to induce arterial proliferation. Many of these genes also stimulate the expression of Egr-1 in vascular cells. These positive feedback loops amplify and sustain gene transcription through Egr-1-mediated mechanisms in vascular proliferative diseases. Cigarette smoking is well known to increase the risk of cardiovascular diseases. Nicotine, the addictive substance in cigarettes, stimulates the sympathetic nervous system and causes endothelial injury. 9 Nicotine also exaggerates arterial neointimal hyperplasia after injury and atherosclerosis in the ApoE knockout mouse. 1 Vazquez-Padron et al. 10 report on their investigation of the mechanisms by which nicotine increases VSMC proliferation and neointimal formation after arterial injury. They showed that nicotine activates the extracellular signal-regulated kinase ERK1/2 through nicotinic acetylcholine receptors to induce mitogenesis in VSMCs. Downstream of ERK1/ 2, nicotine induces phosphorylation of Elk-1 by the up-regulation of Egr-1. Treatment of balloon-injured arteries with a lentivirus vector carrying an shRNA against Egr-1 abolished the deleterious effect of nicotine on vascular remodelling. Thus, nicotine acts through its receptors in VSMCs to activate the ERK/Egr-1 signalling cascade that induces cell proliferation and exacerbates neointimal formation after arterial injury. This study provides new insights into cigarette smoking-related cardiovascular diseases, including the finding that restenosis is accelerated by the activation of Egr-1 by nicotine. Cigarette smoking is also well known to lower levels of HDL cholesterol, one independent risk factor for atherosclerotic vascular disease. HDL cholesterol promotes reverse cholesterol transport to prevent the formation of atherosclerotic plaque by high levels of LDL cholesterol and acts as an anti-inflammatory and antioxidant. 11 Previous studies have shown that cigarette smoke contains reactive oxidants that can enter the bloodstream and cause macromolecular damage in endothelial cells. Cigarette smoking also elicits a marked activation of leucocytes and platelets, which can additionally contribute to the oxidative vascular damage seen in smokers. Furthermore, constituents of cigarette smoke circulating in the blood activate radical oxygen species that induce enzyme systems within the vascular wall and lead to vascular inflammation and development of atherosclerosis. 12 However, stem cells hold great promise for tissue repair and regenerative medicine, and endothelial progenitor cells (EPCs) play a significant role in endothelial repair. Recent studies have shown that cardiovascular risk factors such as hypertension, hypercholesterolaemia, diabetes, and cigarette smoking are inversely correlated with EPC number and function. We found that EPC colony numbers in cigarette smokers are quite low, indicating that cigarette smoking impairs the repair by EPCs of endothelial damage that eventually induces atherosclerotic vascular disease. 13 The mechanisms underlying the vascular diseases related to cigarette smoking are complex. The findings by Vazquez-Padron et al., 10 which reveal that the activation of Egr-1 by nicotine is one possible mechanism by which cigarette smoking induces vascular proliferative disease, may aid in developing a potential treatment for vascular disease in cigarette smokers in the future.
